Decrease of glutathione content in the prefrontal cortical mitochondria of rats with acute hepatic encephalopathy: prevention by histidine

Metab Brain Dis. 2013 Mar;28(1):11-4. doi: 10.1007/s11011-012-9342-6. Epub 2012 Oct 20.

Abstract

Mitochondrial glutathione (mGSH) is a critical factor in the cell defense against oxidative and nitrosative stress (ONS), and ONS is a key pathogenic event in hepatic encephalopathy (HE). Acute HE in the thioacetamide (TAA) model caused a 54 % decrease of mGSH content in the rat prefrontal cortex (pfc), but not in the striatum (str), nor did it affect the GSH content in the pfc or str homogenate. In the pfc, treatment with L- histidine (His), which is known to alleviate ONS-related symptoms in HE animals, attenuated the decrease of mGSH, and increased the GSH content in pfc and str homogenates and pfc microdialysates of control animals. His increased the expression of mRNA coding for the GSH synthesizing enzyme, glutamate cysteine ligase (GCL) and decreased that of the GSH-degrading enzyme γ-glutamyltranspeptidase (γGT). The results suggest that the decrease of mGSH may be an important contributing factor to mitochondrial dysfunction in HE, and delineate a new mechanistic aspect of the therapeutic potential of His in HE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Glutamate-Cysteine Ligase / genetics
  • Glutathione / analysis*
  • Glutathione / metabolism
  • Hepatic Encephalopathy / drug therapy
  • Hepatic Encephalopathy / metabolism*
  • Histidine / therapeutic use*
  • Male
  • Mitochondria / metabolism*
  • Oxidative Stress / drug effects
  • Prefrontal Cortex / metabolism*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Histidine
  • GCLM protein, human
  • Glutamate-Cysteine Ligase
  • Glutathione